在老年人群中用生物假肢取代外科动脉置换后的长期随访期间,痴呆症的发展
Ivo Deblier1, Karl Dossche1, Anthony Vanermen1
1Faculty of Medicine, University of Antwerp, 2610 Antwerp, Belgium.
Journal of cardiovascular development and disease
|May 24, 2024
概括
手术后妄想和晚年是心脏门手术后痴呆症的关键预测因素. 识别这些因素可以帮助改善患者的治疗结果和术后的长期存活率.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 老年病的医生 老年病的医生
背景情况:
- 使用生物心脏门假体 (BHV) 进行外科动脉置换 (SAVR) 的老年患者面临痴呆症风险增加.
- 了解SAVR后痴呆症的预测因素对于这个弱势群体至关重要.
研究的目的:
- 确定SAVR.R后患者痴呆症发展的预测因子.
- 分析术前,术后和术后因素对长期痴呆症发病率的影响.
主要方法:
- 分析了接受SAVR治疗的1500名患者的队列.
- 评估了手术前,手术期间和手术后30天的不良事件.
- 进行了单变量和多变量分析,以确定痴呆症预测因子,平均随访时间为6.8年.
主要成果:
- 在长期随访期间,17.2%的患者患有痴呆症,降低了平均存活率.
- 手术后妄 (OR=3.55) 和80岁以上的年龄 (OR=2.38) 是主要的预测因素.
- 其他重要的预测因素包括术前心房动,心肺旁路时间延长和术后血栓栓塞.
结论:
- 手术后妄和晚年 (>80岁) 是SAVR后痴呆症最重要的预测因素.
- 这些发现强调了管理妄和考虑年龄在SAVR后痴呆症风险评估中的重要性.
更多相关视频
14:14Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
14.1K
05:31Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
2.8K
相关概念视频
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation I: Introduction
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
